Tanvex BioPharma, Inc. got IPO in Taiwan

Taipei, Taiwan, Oct. 26, 2017 Tanvex BioPharma Inc. (“Tanvex”, stock code 6541) went for primary listing on the Taiwan Stock Exchange Corporation (TWSE) on Oct. 26, 2017. We will begin trading shares with an initial public offering of 23M shares of common stock at a...

LipoSeuticals Closes Undisclosed Series A Financing

USA Published on June 29, 2017By FinSMEs LipoSeuticals, Inc. (LSI), a Monmouth Junction, N.J.-based specialty pharmaceutical company, closed a financing round for an undisclosed amount. The round was led by Delos Capital, a Hong Kong based life sciences fund. In...